Pacemaker mode selection: the evidence from randomized trials

Area of Science:

• Cardiology
• Electrophysiology
• Clinical Trials

Background:

• Pacemaker selection guidelines for sinus node dysfunction (SND), atrioventricular block (AVB), and vasovagal syncope predominantly rely on observational data.
• Previous observational studies suggested physiological pacing improves outcomes compared to ventricular pacing, but early randomized trials yielded mixed results.
• The need for large-scale, randomized trials to definitively assess pacemaker benefits and costs is increasingly recognized.

Purpose of the Study:

• To analyze results from completed randomized trials evaluating pacemaker mode selection.
• To assess the efficacy of different pacing modes in patients requiring permanent bradycardia pacing.
• To provide evidence-based insights for optimizing pacemaker therapy.

Main Methods:

• Review and analysis of completed multicenter randomized trials involving over 6,000 patients requiring permanent pacing.
• Comparison of dual-chamber pacing versus ventricular pacing outcomes.
• Inclusion of data from trials conducted in Canada, the United Kingdom, and the United States.

Main Results:

• Dual-chamber pacing did not significantly prevent stroke or improve overall survival compared to ventricular pacing.
• Dual-chamber pacing demonstrated a moderate reduction in incident and chronic atrial fibrillation (AF).
• Dual-chamber pacing improved heart failure symptoms in SND patients, prevented pacemaker syndrome, and enhanced quality of life.

Conclusions:

• Evidence from randomized trials suggests dual-chamber pacing offers benefits beyond stroke prevention and survival, including AF reduction and symptom improvement.
• A potential 5-10% mortality reduction with atrial-based pacing cannot be ruled out.
• Ongoing trials and meta-analyses will further refine the evidence base for pacemaker mode selection.